Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs)

Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs)

Bibliographic Details
Main Authors:	Xinyue Deng, Tong Ge, Kefeng Shen, Jiachen Wang, Wei Mu, Hui Luo, Jia Gu, Meilan Zhang, Min Xiao
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2024-01-01
Series:	Blood Science
Online Access:	http://journals.lww.com/10.1097/BS9.0000000000000180

Similar Items

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease
by: Kefeng Shen, et al.
Published: (2023-01-01)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
by: Yoshitaka Sato
Published: (2018-11-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

EBV and the Pathogenesis of NK/T Cell Lymphoma
by: Ivonne A. Montes-Mojarro, et al.
Published: (2021-03-01)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
by: Honami Takada, et al.
Published: (2017-01-01)

Treatment Advances in EBV Related Lymphoproliferative Diseases
by: Kebing Lv, et al.
Published: (2022-04-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
by: Stefan D. Dojcinov, et al.
Published: (2018-03-01)

Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma
by: Zhiwei Liu, et al.
Published: (2021-12-01)

Systemic EBV T-Cell Lymphoproliferative Disease of Young Adults
by: Zahedin Kheyri, et al.
Published: (2014-04-01)

EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma
by: Cao-Li Tang, et al.
Published: (2024-01-01)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
by: Kwai Fung Hui, et al.
Published: (2019-02-01)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
by: Polina Shindiapina, et al.
Published: (2020-09-01)

The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies
by: Maria G. Desimio, et al.
Published: (2023-03-01)

Primary intestinal NK-cell lymphoma, EBV-negative: A case report and literature review
by: Matthew Koo, et al.
Published: (2019-09-01)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
by: Moussab Tatfi, et al.
Published: (2019-01-01)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
by: Göksenil BÜLBÜL, et al.
Published: (2022-05-01)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
by: Elshafa Hassan Ahmed, et al.
Published: (2021-05-01)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
by: Thomas Mika, et al.
Published: (2019-12-01)

Fatal familial hemophagocytic lymphohistiocytosis with perforin gene (PRF1) mutation and EBV-associated T-cell lymphoproliferative disorder of the thyroid
by: Agrima Mian, et al.
Published: (2019-08-01)

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas
by: Hannes Vietzen, et al.
Published: (2023-06-01)

EBV & lymphoma
by: Dolores Caballero, (Coordinating Author)
Published: (2019-06-01)

EBV and Lymphomagenesis
by: Daniel G. Sausen, et al.
Published: (2023-04-01)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
by: Qiuting Zhang, et al.
Published: (2023-09-01)

Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
by: Susan Swee-Shan Hue, et al.
Published: (2022-05-01)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
by: Wook Youn Kim, et al.
Published: (2019-03-01)

Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR− NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
by: Janice K. P. Lam, et al.
Published: (2020-06-01)

Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
by: Mayumi Yoshimori, et al.
Published: (2021-10-01)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
by: Mikhail Y. Salnikov, et al.
Published: (2023-03-01)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
by: Ting Liu, et al.
Published: (2023-06-01)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
by: Octavia Ramayanti, et al.
Published: (2018-03-01)

Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy
by: Mohamad Sabbah, et al.
Published: (2021-08-01)

Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
by: Sergio Mazzola Poli de Figueiredo, MD, et al.
Published: (2022-09-01)

EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency
by: Akira Satou, et al.
Published: (2021-10-01)

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
by: Nicole Caduff, et al.
Published: (2020-04-01)

Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease
by: Juliana Ordoñez-Parra, et al.
Published: (2021-07-01)

PB2086: CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS WITH LIVER INFILTRATION
by: V. Otasevic, et al.
Published: (2022-06-01)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
by: Sanjay de Mel, et al.
Published: (2019-01-01)